Concert Pharmaceuticals Inc CNCE

NEW YORK, Jan. 21, 2023 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders.  Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies:

• Neovasc Inc. (NASDAQ: NVCN)

Neovasc has agreed to merge with Shockwave Medical. Under the proposed transaction, Neovasc shareholders will receive $27.25 in cash per share.

• Volta Inc. (NYSE: VLTA)

Volta has agreed to merge with Shell USA. Under the proposed transaction, Volta shareholders will receive $0.86 in cash per share.

• Concert Pharmaceuticals, Inc. (NASDAQ: CNCE)

Concert Pharmaceuticals has agreed to merge with Sun Pharmaceutical. Under the proposed transaction, Concert Pharmaceuticals shareholders will receive $3.50 in cash per share.

• Angion Biomedica Corp (NASDAQ: ANGN)

Angion Biomedica has agreed to merge with Elicio Therapeutics. Under the proposed transaction, Angion Biomedica shareholders are expected to own approximately 34.5% of the combined company.

Moore Kuehn is investigating whether the Boards of the above companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process. 

Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq. by email at jkuehn@moorekuehn.com.  The consultation and case are free with no obligation to you.  Moore Kuehn pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

Moore Kuehn is a 5-star Google client-rated New York City law firm with attorneys representing investors and consumers in litigation involving securities laws, fraud, breaches of fiduciary duties, and other claims.  For additional information about Moore Kuehn, please visit http://www.moorekuehn.com/practice/new-york-securities-litigation/.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Moore Kuehn, PLLC
Justin Kuehn, Esq.
30 Wall Street, 8^th Floor
New York, New York 10005
jkuehn@moorekuehn.com
(212) 709-8245

View original content to download multimedia:https://www.prnewswire.com/news-releases/moore-kuehn-encourages-nvcn-vlta-cnce-and-angn-investors-to-contact-law-firm-301727683.html

SOURCE Moore Kuehn, PLLC